OTCMKTS:PBSV

Pharma-Bio Serv (PBSV) Stock Price, News & Analysis

$0.70
-0.10 (-12.50%)
(As of 04/22/2024 ET)
Today's Range
$0.70
$0.70
50-Day Range
$0.70
$0.97
52-Week Range
$0.65
$1.10
Volume
1,161 shs
Average Volume
1,640 shs
Market Capitalization
$16.07 million
P/E Ratio
23.34
Dividend Yield
N/A
Price Target
N/A
PBSV stock logo

About Pharma-Bio Serv Stock (OTCMKTS:PBSV)

Pharma-Bio Serv, Inc. operates as a compliance and technology transfer services consulting firm in Puerto Rico, the United States, Europe, Brazil, and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support for the pharmaceutical, chemical manufacturing, biotechnology, medical device, cosmetic, food industries, and allied products companies. Pharma-Bio Serv, Inc. was founded in 1993 and is headquartered in Dorado, Puerto Rico.

PBSV Stock Price History

PBSV Stock News Headlines

SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
PBSV Releases Quarterly Results
Pharma-Bio Serv reports Q1 results
SHOCKING Crypto Leak…
A shocking leak has revealed tech giant Microsoft's plans to add crypto support to future products. If the plans in these leaked internal documents pan out, we could see prices skyrocket for Bitcoin, Ethereum, XRP and MORE… The coupling of gaming and cryptocurrency could absolutely transform digital finance as we know it in 2024.
PBSV Expands Margins and Markets
PBSV Reward Shareholders with High Yield
PBSV Boosts Margins and Expands Markets
Pharma-Bio Serv Inc
See More Headlines
Receive PBSV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pharma-Bio Serv and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Ex-Dividend for 2/15 Dividend
1/29/2024
Dividend Payable
2/15/2024
Last Earnings
3/18/2024
Today
4/23/2024
Next Earnings (Estimated)
6/12/2024
Fiscal Year End
10/31/2024

Industry, Sector and Symbol

Industry
Management consulting services
Sub-Industry
N/A
Current Symbol
OTCMKTS:PBSV
Employees
100
Year Founded
N/A

Profitability

Net Income
$1.31 million
Pretax Margin
5.65%

Debt

Sales & Book Value

Annual Sales
$16.98 million
Cash Flow
$0.06 per share
Book Value
$0.70 per share

Miscellaneous

Free Float
20,162,000
Market Cap
$16.07 million
Optionable
Not Optionable
Beta
0.51
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Victor Sanchez (Age 53)
    CEO, President & President of European Operations
    Comp: $323.67k
  • Mr. Pedro J. Lasanta (Age 64)
    CFO, VP of Finance & Administration and Secretary
    Comp: $225.6k
  • Ms. Elizabeth Plaza (Age 60)
    Founder & Senior Strategic Consultant
    Comp: $69.92k
  • Ms. Miriam Marrero M.B.A.
    Human Resources Manager

PBSV Stock Analysis - Frequently Asked Questions

How have PBSV shares performed in 2024?

Pharma-Bio Serv's stock was trading at $1.05 on January 1st, 2024. Since then, PBSV stock has decreased by 33.3% and is now trading at $0.70.
View the best growth stocks for 2024 here
.

When is Pharma-Bio Serv's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our PBSV earnings forecast
.

How were Pharma-Bio Serv's earnings last quarter?

Pharma-Bio Serv, Inc. (OTCMKTS:PBSV) released its earnings results on Monday, March, 18th. The company reported ($0.01) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $0.02 by $0.03. The firm earned $2.38 million during the quarter, compared to the consensus estimate of $5 million. Pharma-Bio Serv had a net margin of 4.05% and a trailing twelve-month return on equity of 3.95%.

How often does Pharma-Bio Serv pay dividends? What is the dividend yield for Pharma-Bio Serv?

Pharma-Bio Serv declared a dividend on Thursday, December 21st. Shareholders of record on Tuesday, January 30th will be given a dividend of $0.075 per share on Thursday, February 15th. The ex-dividend date of this dividend is Monday, January 29th.
Read our dividend analysis for PBSV
.

What other stocks do shareholders of Pharma-Bio Serv own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Pharma-Bio Serv investors own include Zynerba Pharmaceuticals (ZYNE), Allena Pharmaceuticals (ALNA), AstroNova (ALOT), Oracle (ORCL), AT&T (T), Yintech Investment (YIN), Aeglea BioTherapeutics (AGLE), Ampliphi Biosciences (APHB), Carnival Co. & (CCL) and Earthstone Energy (ESTE).

How do I buy shares of Pharma-Bio Serv?

Shares of PBSV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (OTCMKTS:PBSV) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners